Equities

Jiangsu Hengrui Pharmaceuticals Co Ltd

600276:SHH

Jiangsu Hengrui Pharmaceuticals Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)44.77
  • Today's Change-5.69 / -11.28%
  • Shares traded19.51m
  • 1 Year change-5.91%
  • Beta1.0805
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Jiangsu Hengrui Pharmaceuticals Co Ltd (600276:SHH) closed at 44.77, 26.08% above the 52 week low of 35.51 set on Feb 02, 2024.
52-week range
Today
35.51Feb 02 202457.53Oct 08 2024
Open44.95
High45.30
Low44.40
Bid44.77
Offer44.78
Previous close50.46
Average volume52.84m
Shares outstanding6.38bn
Free float3.34bn
P/E (TTM)59.37
Market cap321.88bn CNY
EPS (TTM)0.8499
CNY
Annual div (ADY)0.20
CNY
Annual div yield (ADY)0.40%
Div ex-dateJul 12 2024
Div pay-dateJul 12 2024
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼

FT News

Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.